Protection against age-dependent renal injury in the F344xBrown Norway male rat is associated with maintained nitric oxide synthase

Mechanisms of Ageing and Development

Volumn 132, Issue 1-2, 2011, Pages 1-7

  Moningka, Natasha C ^a   Sasser, Jennifer M ^a   Croker, Byron ^a   Carter, Christy ^a   Baylis, Chris ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Asymmetric dimethylarginine; Oxidative stress; Rat strain difference; Renin angiotensin system blockade; Tubulointerstitial injury

Indexed keywords

6 N,N' DIMETHYLARGININE; ANGIOTENSIN RECEPTOR ANTAGONIST; ARGININE; CANDESARTAN; COPPER ZINC SUPEROXIDE DISMUTASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROGEN PEROXIDE; MANGANESE SUPEROXIDE DISMUTASE; N(G),N(G) DIMETHYLARGININE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; PLACEBO; SUPEROXIDE DISMUTASE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME DEFICIENCY; GLOMERULOSCLEROSIS; KIDNEY INJURY; KIDNEY TUBULE DAMAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION; TREATMENT OUTCOME;

AGING; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ARGININE; KIDNEY; MALE; MODELS, ANIMAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; RATS; RATS, INBRED BN; RATS, INBRED F344; RENIN-ANGIOTENSIN SYSTEM; SPECIES SPECIFICITY;

RATTUS; RATTUS NORVEGICUS;

EID: 79251599654     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2010.10.004     Document Type: Article

References (33)

1. Anderson S., Rennke H.G., Zatz R. Glomerular adaptations with normal aging and with long-term converting enzyme inhibition in rats. Am. J. Physiol. 1994, 267:F35-43.
2. Baumhakel M., Bohm M. Telmisartan prevents cardiovascular events in a broad group of at-risk patients. Expert Opin. Pharmacother. 2009, 10:3113-3117.
3. Baylis C. Nitric oxide deficiency in chronic kidney disease. Am. J. Physiol. Renal. Physiol. 2008, 294:F1-9.
4. Baylis C. Sexual dimorphism in the aging kidney: differences in the nitric oxide system. Nat. Rev. Nephrol. 2009, 5:384-396.
5. Baylis C. Sexual dimorphism, the aging kidney, and involvement of nitric oxide deficiency. Semin. Nephrol. 2009, 29:569-578.
6. Baylis C., Corman B. The aging kidney: insights from experimental studies. J. Am. Soc. Nephrol. 1998, 9:699-709.
7. Berry C., Norrie J., McMurray J.J. Are angiotensin II receptor blockers more efficacious than placebo in heart failure? Implications of ELITE-2 evaluation of Losartan in the elderly. Am. J. Cardiol. 2001, 87:606-607. A9.
8. Bode-Boger S.M., Muke J., Surdacki A., Brabant G., Boger R.H., Frolich J.C. Oral l-arginine improves endothelial function in healthy individuals older than 70 years. Vasc. Med. 2003, 8:77-81.
9. Boger R.H., Sydow K., Borlak J., Thum T., Lenzen H., Schubert B., Tsikas D., Bode-Boger S.M. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ. Res. 2000, 87:99-105.
10. Diz D., Lewis K. Dahl memorial lecture: the renin-angiotensin system and aging. Hypertension 2008, 52:37-43.
11. Erdely A., Greenfeld Z., Wagner L., Baylis C. Sexual dimorphism in the aging kidney: effects on injury and nitric oxide system. Kidney Int. 2003, 63:1021-1026.
12. Erdely A., Wagner L., Muller V., Szabo A., Baylis C. Protection of wistar furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase. J. Am. Soc. Nephrol. 2003, 14:2526-2533.
13. Gill P.S., Wilcox C.S. NADPH oxidases in the kidney. Antioxid. Redox Signal. 2006, 8:1597-1607.
14. Griffiths R.D. Muscle mass, survival, and the elderly ICU patient. Nutrition 1996, 12:456-458.
15. Heudes D., Michel O., Chevalier J., Scalbert E., Ezan E., Bariety J., Zimmerman A., Corman B. Effect of chronic ANG I-converting enzyme inhibition on aging processes. I. Kidney structure and function. Am. J. Physiol. 1994, 266:R1038-R1051.
16. Kasiske B.L. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int. 1987, 31:1153-1159.
17. Kasper S.O., Gilliam-Davis S., Groban L., Carter C.S., Sonntag W.E., Chappell M.C., Diz D.I. Effects of aging and renin-angiotensin system (RAS) blockade on the intra-renal RAS in older Fischer 344xBrown Norway rats [abstract]. FASEB J. 2008, 12. 735.11.
18. Kielstein J.T., Bode-Boger S.M., Frolich J.C., Ritz E., Haller H., Fliser D. Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation 2003, 107:1891-1895.
19. Lindeman R.D., Tobin J., Shock N.W. Longitudinal studies on the rate of decline in renal function with age. J. Am. Geriatr. Soc. 1985, 33:278-285.
20. Lipman R.D., Chrisp C.E., Hazzard D.G., Bronson R.T. Pathologic characterization of brown Norway, brown Norway x Fischer 344, and Fischer 344xbrown Norway rats with relation to age. J. Gerontol. A Biol. Sci. Med. Sci. 1996, 51:B54-B59.
21. Lombardi D., Gordon K.L., Polinsky P., Suga S., Schwartz S.M., Johnson R.J. Salt-sensitive hypertension develops after short-term exposure to angiotensin II. Hypertension 1999, 33:1013-1019.
22. Marcovecchio M.L., Dalton R.N., Turner C., Prevost A.T., Widmer B., Amin R., Dunger D.B. Symmetric dimethylarginine, an endogenous marker of glomerular filtration rate, and the risk for microalbuminuria in young people with type 1 diabetes. Arch. Dis. Child 2009, 95:119-124.
23. McLachlan M.S., Guthrie J.C., Anderson C.K., Fulker M.J. Vascular and glomerular changes in the ageing kidney. J. Pathol. 1977, 121:65-78.
24. Mistry S.K., Greenfeld Z., Morris S.M., Baylis C. The 'intestinal-renal' arginine biosynthetic axis in the aging rat. Mech. Ageing Dev. 2002, 123:1159-1165.
25. Modlinger P., Chabrashvili T., Gill P.S., Mendonca M., Harrison D.G., Griendling K.K., Li M., Raggio J., Wellstein A., Chen Y., Welch W.J., Wilcox C.S. RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response. Hypertension 2006, 47:238-244.
26. Nicholson T.B., Chen T., Richard S. The physiological and pathophysiological role of PRMT1-mediated protein arginine methylation. Pharmacol. Res. 2009, 60:466-474.
27. Ortmann J., Kerstin A., Brandes R.P., Kretzler M., Munte K., Parkh N., Traupe T., Lange M., Lattmann T., Barton M. Role of podocytes for reverseal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition. Hypertension 2004, 44:974-981.
28. Palm F., Onozato M.L., Luo Z., Wilcox C.S. Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3227-H3245.
29. Sasser J.M., Moningka N.C., Cunningham M.W., Croker B.P., Baylis C. Asymmetric dimethylarginine in angiotensin II induced hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009.
30. Schindler C. ACE-inhibitor AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET. Ther. Adv. Cardiovasc. Dis. 2008, 2:233-248.
31. Schulze F., Maas R., Freese R., Schwedhelm E., Silberhorn E., Boger R.H. Determination of a reference value for N(G) N(G)-dimethyl-l-arginine in 500 subjects. Eur. J. Clin. Invest. 2005, 35:622-626.
32. Wheeler H.E., Metter E.J., Tanaka T., Absher D., Higgins J., Zahn J.M., Wilhelmy J., Davis R.W., Singleton A., Myers R.M., Ferrucci L., Kim S.K. Sequential use of transcriptional profiling, expression quantitative trait mapping, and gene association implicates MMP20 in human kidney aging. PLoS Genet. 2009, 5:e1000685.
33. Xiong Y., Yuan L.W., Deng H.W., Li Y.J., Chen B.M. Elevated serum endogenous inhibitor of nitric oxide synthase and endothelial dysfunction in aged rats. Clin. Exp. Pharmacol. Physiol. 2001, 28:842-847.